GSK plc’s Senseonics Holdings Inc SENS Stock Holding History

GSK plc’s Portfolio SENS Stock Details SENS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,856	Closed	-$59.9K	–	15
2025 Q4	$59.9K	Buy	+10,856	New	+$75.5K	0.01%	14

Other funds holding SENS

Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

GSK plc's SENS Position: Q1 2026 in Review

GSK plc sold out of Senseonics Holdings Inc (SENS) in Q1 2026, closing a stake of 10,856 shares — an estimated $59.9K sold.

GSK plc first reported a position in SENS in Q4 2025 and held it in 1 quarter. The position peaked at $59.9K in Q4 2025. 88 funds tracked by Wall St. Rank hold SENS as of Q1 2026.

GSK plc reported no remaining Senseonics Holdings Inc position as of Q1 2026 after selling out during the quarter.
GSK plc sold 10,856 Senseonics Holdings Inc shares in Q1 2026, an estimated $59.9K.
GSK plc first reported a position in Senseonics Holdings Inc in Q4 2025 and held it in 1 quarter.
GSK plc's Senseonics Holdings Inc position peaked at $59.9K in Q4 2025.
88 funds tracked by Wall St. Rank held Senseonics Holdings Inc as of Q1 2026.

Based on GSK plc's 13F filing for Q1 2026, filed 14 May 2026.